营养基因组学市场规模、份额和增长分析：按产品、按技术、按应用、按最终用途、按地区 - 行业预测，2024-2031 年

2022年全球营养基因组学市场规模将为3.862亿美元，从2023年的4.5379亿美元增长到2031年的16.4874亿美元，预计在预测期内（2024-2031年）将以17.50的复合年增长率增长。

未来几年，全球营养基因组学市场预计将成长，主要是由于慢性病盛行率上升。过去十年中蛋白质组学、基因组学和代谢体学的进步显着提高了我们透过分析蛋白质途径来识别疾病的能力，特别是在糖尿病、癌症和肥胖等受饮食选择影响的疾病中。营养基因组学探讨食品和基因表现之间的相互作用，深入了解不同的饮食成分如何改变个体的基因谱。然而，他们也面临着有关基因研究和测试的政府法规的挑战，这些法规阻碍了营养基因组学产品和服务的市场开拓。联邦、州或地方政府实施的更严格的法律可能会使基因检测变得更加繁重，并影响其在临床管理和研究中的采用。使情况更加复杂的是，各地区与直接面向消费者的测试（DTC）相关的法律存在巨大差异，这为涉足营养基因组学的公司造成了重大障碍。因此，虽然市场扩张潜力巨大，但对于旨在向消费者提供创新营养基因组学测试解决方案的公司来说，监管障碍预计将是需要考虑的关键因素。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析与影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 案例研究分析
• PESTEL分析
• 市场吸引力指数
• 价格分析

全球营养基因体学市场规模：依产品分類的复合年增长率（2024-2031）

• 市场概况
• 试剂/套件
• 服务

全球营养基因体学市场规模：依技术分類的复合年增长率（2024-2031）

• 市场概况
• 唾液
• 颊黏膜拭子
• 血

全球营养基因组学市场规模：按应用/复合年增长率（2024-2031）

• 市场概况
• 肥胖
• 心血管疾病
• 癌症研究
• 其他的

全球营养基因体学市场规模：依最终用途分類的复合年增长率（2024-2031）

• 市场概况
• 医院/诊所
• 网路平台
• 其他的

全球营养基因体学市场规模/复合年增长率（2024-2031）

• 北美（产品、技术、应用、最终用途）
  • 美国
  • 加拿大
• 欧洲（产品、技术、应用、最终用途）
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区（产品、技术、应用、最终用途）
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲（产品、技术、应用、最终用途）
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲（产品、技术、应用、最终用途）
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Nutrigenomix
• The Gene Box
• Metagenics
• Xcode Life
• GX Sciences, LLC（Fagron）
• Cura Integrative Medicine
• DNAlife
• Genova Diagnostics（GDX）
• Holistic Health International, Llc
• Vitagene
• Mapmygenome
• GeneOmbio
• 23andMe Inc.
• DNAfit
• GX Sciences Inc.
• Amway
• Herbalife Nutrition Ltd.
• DSM Nutritional Products
• Syngene International

结论和建议

Global Nutrigenomics Market size was valued at USD 386.20 million in 2022 and is poised to grow from USD 453.79 million in 2023 to USD 1648.74 million by 2031, growing at a CAGR of 17.50% during the forecast period (2024-2031).

In the coming years, the global nutrigenomics market is poised for growth, largely driven by the rising prevalence of chronic illnesses. The advancements in proteomics, genomics, and metabolomics over the past decade have significantly enhanced the ability to identify diseases by analyzing protein pathways, especially in conditions like diabetes, cancer, and obesity, which are influenced by dietary choices. Nutrigenomics explores the interplay between food and gene expression, offering insights into how various dietary components can modify an individual's genetic profile. However, the market faces challenges from government regulations surrounding genetic research and testing, which can hamper the development of nutrigenomics products and services. Stricter laws imposed by federal, state, or local authorities can make genetic testing more cumbersome, affecting its adoption in clinical management and research. Additionally, the inconsistency of legislation related to direct-to-consumer (DTC) testing in different regions further complicates the landscape, creating a significant barrier for companies engaged in nutrigenomics. As a result, while there is substantial potential for market expansion, regulatory hurdles will be an important factor to consider for businesses aiming to innovate and bring nutrigenomics testing solutions to consumers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nutrigenomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nutrigenomics Market Segmental Analysis

Global Nutrigenomics Market is segmented into Product, Technique, Application, End Use, and region. By Product, the market is classified into Reagents & Kits, and Services. Depending on the Technique, it is categorized into Saliva, Buccal Swab, Blood. According to Application, the market is divided into Obesity, Cardiovascular Diseases, Cancer Research, Other. Based on End Use, the market is segmented into Hospitals & Clinics, Online Platforms, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Nutrigenomics Market

The global nutrigenomics market is witnessing significant growth driven by the escalating prevalence of chronic diseases, such as obesity, diabetes, and cardiovascular conditions. As these health issues become more prevalent, there is a growing demand for personalized nutrition that takes individual genetic factors into account. This customization of dietary approaches not only aids in the prevention and management of these ailments but also stimulates increased investments in tailored nutrition strategies. Consequently, the focus on nutrigenomics, which integrates genetic insights into dietary planning, is propelling market expansion and offering innovative solutions for better health outcomes globally.

Restraints in the Global Nutrigenomics Market

The global nutrigenomics market encounters significant challenges due to limited scientific evidence supporting the effectiveness of personalized nutrition interventions. While research in this area has shown potential, there remains a lack of extensive clinical validation and large-scale studies that demonstrate the long-term benefits of these solutions. Consequently, this uncertainty leads to skepticism among health care professionals and hesitance among consumers, ultimately impacting the overall acceptability and adoption of nutrigenomic solutions. The absence of robust data to substantiate claims about personalized nutrition hampers the market's growth and poses a considerable restraint on its development on a global scale.

Market Trends of the Global Nutrigenomics Market

The global nutrigenomics market is experiencing a significant trend towards personalized nutrition, driven by advancements in genetic testing and data analytics. Consumers are increasingly seeking tailored dietary solutions that align with their unique genetic profiles, which results in optimized health outcomes and preventive care. This surge is further amplified by the growing awareness of the relationship between genes, diet, and health, alongside increasing consumer demand for personalized health interventions. As companies innovate to offer customized nutritional plans, the market is poised for robust growth, with a wide range of applications in personal health management, chronic disease prevention, and overall wellness enhancement.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Case Study Analysis
• PESTEL Analysis
• Market Attractiveness Index
• Pricing Analysis

Global Nutrigenomics Market Size by Product & CAGR (2024-2031)

• Market Overview
• Reagents & Kits
• Services

Global Nutrigenomics Market Size by Technique & CAGR (2024-2031)

• Market Overview
• Saliva
• Buccal Swab
• Blood

Global Nutrigenomics Market Size by Application & CAGR (2024-2031)

• Market Overview
• Obesity
• Cardiovascular Diseases
• Cancer Research
• Others

Global Nutrigenomics Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Hospitals & Clinics
• Online Platforms
• Others

Global Nutrigenomics Market Size & CAGR (2024-2031)

• North America, (Product, Technique, Application, End Use)
  • US
  • Canada
• Europe, (Product, Technique, Application, End Use)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Technique, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Technique, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Technique, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Nutrigenomix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Gene Box
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metagenics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xcode Life
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GX Sciences, LLC (Fagron)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cura Integrative Medicine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNAlife
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genova Diagnostics (GDX)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Holistic Health International, Llc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitagene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mapmygenome
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneOmbio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 23andMe Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNAfit
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GX Sciences Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amway
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Herbalife Nutrition Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM Nutritional Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syngene International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation